SK281806B6 - Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus - Google Patents

Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus Download PDF

Info

Publication number
SK281806B6
SK281806B6 SK423-95A SK42395A SK281806B6 SK 281806 B6 SK281806 B6 SK 281806B6 SK 42395 A SK42395 A SK 42395A SK 281806 B6 SK281806 B6 SK 281806B6
Authority
SK
Slovakia
Prior art keywords
cells
insulin
diabetes mellitus
iddm
diabetes
Prior art date
Application number
SK423-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK42395A3 (en
Inventor
Martha W. Bond
Kevin W. Moore
Kenneth Pennline
Paul J. M. Vieira
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SK42395A3 publication Critical patent/SK42395A3/sk
Publication of SK281806B6 publication Critical patent/SK281806B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK423-95A 1992-10-01 1993-09-28 Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus SK281806B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95552392A 1992-10-01 1992-10-01
PCT/US1993/009030 WO1994008606A1 (en) 1992-10-01 1993-09-28 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus

Publications (2)

Publication Number Publication Date
SK42395A3 SK42395A3 (en) 1997-01-08
SK281806B6 true SK281806B6 (sk) 2001-08-06

Family

ID=25496932

Family Applications (1)

Application Number Title Priority Date Filing Date
SK423-95A SK281806B6 (sk) 1992-10-01 1993-09-28 Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus

Country Status (24)

Country Link
EP (1) EP0662837B1 (sv)
JP (1) JP2739770B2 (sv)
KR (1) KR0166663B1 (sv)
CN (1) CN1093598A (sv)
AT (1) ATE180168T1 (sv)
AU (1) AU689448B2 (sv)
CA (1) CA2145863A1 (sv)
CZ (1) CZ286866B6 (sv)
DE (1) DE69325029T2 (sv)
DK (1) DK0662837T3 (sv)
ES (1) ES2131122T3 (sv)
FI (1) FI951511A (sv)
GR (1) GR3030269T3 (sv)
HK (1) HK1008812A1 (sv)
HU (1) HU217871B (sv)
IL (1) IL107153A (sv)
MX (1) MX9306043A (sv)
MY (1) MY111543A (sv)
NO (1) NO951240L (sv)
SG (1) SG48733A1 (sv)
SK (1) SK281806B6 (sv)
TW (1) TW336172B (sv)
WO (1) WO1994008606A1 (sv)
ZA (1) ZA937244B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027500A1 (en) * 1994-04-08 1995-10-19 Brigham And Women's Hospital TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
US6410008B1 (en) 1994-12-12 2002-06-25 Beth Israel Hospital Association Chimeric IL-10 proteins and uses thereof
EP1621206A1 (en) * 1994-12-12 2006-02-01 Beth Israel Deaconess Medical Center, Inc. Chimeric cytokines and uses thereof
AU6763496A (en) * 1995-08-07 1997-03-05 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US5939069A (en) 1996-08-23 1999-08-17 University Of Florida Materials and methods for detection and treatment of immune system dysfunctions
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
WO1999006059A2 (en) * 1997-07-30 1999-02-11 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
NZ504465A (en) * 1997-10-14 2001-11-30 Welfide Corp 1-Phenylacylamino substituted piperazine derivatives which are 4-substituted by a heteroaryl group
JP2002289768A (ja) 2000-07-17 2002-10-04 Rohm Co Ltd 半導体装置およびその製法
CN100515491C (zh) * 2005-01-04 2009-07-22 健能隆医药技术（上海）有限公司 白介素-22的医药用途
JP6403062B2 (ja) * 2012-12-21 2018-10-10 国立大学法人徳島大学 組織修復活性組成物及びその利用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
WO2017181143A1 (en) 2016-04-15 2017-10-19 Generon (Shanghai) Corporation, Ltd. Use of il-22 in treating necrotizing enterocolitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
EP0662837B1 (en) 1999-05-19
AU689448B2 (en) 1998-04-02
HU9500933D0 (en) 1995-05-29
HU217871B (hu) 2000-04-28
SK42395A3 (en) 1997-01-08
IL107153A0 (en) 1993-12-28
AU5163593A (en) 1994-05-09
ATE180168T1 (de) 1999-06-15
MX9306043A (es) 1994-04-29
NO951240L (no) 1995-05-30
HUT71421A (en) 1995-11-28
HK1008812A1 (en) 1999-05-21
CZ286866B6 (en) 2000-07-12
FI951511A0 (sv) 1995-03-30
CZ80495A3 (en) 1996-01-17
DK0662837T3 (da) 1999-11-08
ZA937244B (en) 1994-06-27
TW336172B (en) 1998-07-11
MY111543A (en) 2000-08-30
KR0166663B1 (en) 1999-01-15
FI951511A (sv) 1995-03-30
GR3030269T3 (en) 1999-08-31
CA2145863A1 (en) 1994-04-28
JPH07507567A (ja) 1995-08-24
JP2739770B2 (ja) 1998-04-15
DE69325029D1 (de) 1999-06-24
CN1093598A (zh) 1994-10-19
KR950703353A (ko) 1995-09-20
ES2131122T3 (es) 1999-07-16
SG48733A1 (en) 1998-05-18
IL107153A (en) 2000-07-16
WO1994008606A1 (en) 1994-04-28
DE69325029T2 (de) 1999-10-07
NO951240D0 (no) 1995-03-30
EP0662837A1 (en) 1995-07-19

Similar Documents

Publication Publication Date Title
Pennline et al. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
Wiend et al. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials
AU2018201965B2 (en) CTLA4 fusion proteins for the treatment of diabetes
SK281806B6 (sk) Použitie il-10 na prípravu liečiva na prevenciu diabetes mellitus
Adorini Cytokine-based immunointervention in the treatment of autoimmune diseases
US5753218A (en) Method for treating inflammation
US5827513A (en) Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
JP2002532556A (ja) Ｃ型肝炎ウイルス感染のインターロイキン−１０での処置
Weetman et al. Cytokines and Graves' disease
US5601815A (en) IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
Willenborg et al. Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis
JPH06298662A (ja) 自己免疫疾患の予防治療剤
NZ256764A (en) Il-10 medicament for treatment of diabetes
AU699217B2 (en) Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases, allergic disorders, and graft rejection
US20240148827A1 (en) Methods and Compositions for Treatment of Disease
JP2007070367A (ja) Ｃｍｌ治療
JP2000513321A (ja) インターロイキン１０での急性白血病の処置
Meilof et al. Successful recovery after high-dose intravenous methylprednisolone in acute hemorrhagic leukoencephalitis
MXPA98008947A (es) Metodo para tratar la inflamacion